Nasal spray with isotonic saline

DEVICE2 trials

Sponsors

Sanotize Research and Development corp.

Conditions

Recurrent Acute RhinosinusitisSARS-CoV-2 Infection

Phase 2

Evaluation of Nitric Oxide Nasal Spray (NONS) for Treatment of Recurrent Acute Rhinosinusitis

CompletedNCT06264141

Sanotize Research and Development corp.Recurrent Acute Rhinosinusitis

Start: 2024-01-16End: 2025-11-22Updated: 2026-04-22

Phase 3

Nitric Oxide Nasal Spray (NONS) as Prevention for Treatment of Individuals at Risk of Exposure to COVID-19 Infection

TerminatedNCT05109611

Sanotize Research and Development corp.SARS-CoV-2 Infection

Start: 2021-11-20End: 2024-04-30Updated: 2025-09-25